Neurogene Ownership 2024 | Who Owns Neurogene Now?
Institutional Ownership
31.40%
Insider Ownership
16.46%
Retail Ownership
52.14%
Institutional Holders
36.00
Neurogene Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -821,972 | -100.00% | - | Sep 30, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -175 | -100.00% | - | Sep 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -301,057 | -100.00% | - | Sep 30, 2023 |
| BAKER BROS. ADVISORS LP | - | - | - | -3,821,740 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -483,948 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -1,100 | -100.00% | - | Sep 30, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
| ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,500 | -100.00% | - | Sep 30, 2023 |
| SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
Neurogene's largest institutional shareholder is US BANCORP \DE\, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -821,972 | -100.00% | - | Sep 30, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -175 | -100.00% | - | Sep 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -301,057 | -100.00% | - | Sep 30, 2023 |
| BAKER BROS. ADVISORS LP | - | - | - | -3,821,740 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -483,948 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -1,100 | -100.00% | - | Sep 30, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
| ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,500 | -100.00% | - | Sep 30, 2023 |
| SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
The largest Neurogene shareholder by % of total assets is US BANCORP \DE\. The company owns 0.00 shares of Neurogene (NLTX), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -175 | -100.00% | - | Sep 30, 2023 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -925 | -100.00% | - | Sep 30, 2023 |
| - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 | |
| UBS GROUP AG | - | - | - | -1,100 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,500 | -100.00% | - | Sep 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
| SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
| US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
| ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
| PRIVIUM FUND MANAGEMENT (UK) LTD | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
| PRIVIUM FUND MANAGEMENT B.V. | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Neurogene's largest institutional buyer is NATIONAL BANK OF CANADA /FI/. The company purchased -0.17K stocks of NLTX, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | - | - | - | -3,821,740 | -100.00% | - | Sep 30, 2023 |
| LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -3,094,554 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -821,972 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -483,948 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -301,057 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
| PRIVIUM FUND MANAGEMENT B.V. | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
| PRIVIUM FUND MANAGEMENT (UK) LTD | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
| ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
| US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
| SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Neurogene's biggest institutional seller is BAKER BROS. ADVISORS LP. The company sold -3.82M shares of NLTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | - | - | - | -3,821,740 | -100.00% | - | Sep 30, 2023 |
| LYNX1 CAPITAL MANAGEMENT LP | - | - | - | -3,094,554 | -100.00% | - | Sep 30, 2023 |
| MORGAN STANLEY | - | - | - | -821,972 | -100.00% | - | Sep 30, 2023 |
| BLACKROCK INC. | - | - | - | -483,948 | -100.00% | - | Sep 30, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -301,057 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA INVESTMENTS, LP | - | - | - | -211,194 | -100.00% | - | Sep 30, 2023 |
| TWO SIGMA ADVISERS, LP | - | - | - | -184,500 | -100.00% | - | Sep 30, 2023 |
| POINT72 ASSET MANAGEMENT, L.P. | - | - | - | -136,675 | -100.00% | - | Sep 30, 2023 |
| PRIVIUM FUND MANAGEMENT B.V. | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
| PRIVIUM FUND MANAGEMENT (UK) LTD | - | - | - | -117,200 | -100.00% | - | Sep 30, 2023 |
| ALTA FUNDAMENTAL ADVISERS LLC | - | - | - | -89,702 | -100.00% | - | Sep 30, 2023 |
| NORTHERN TRUST CORP | - | - | - | -69,541 | -100.00% | - | Sep 30, 2023 |
| HIGHTOWER ADVISORS, LLC | - | - | - | -48,409 | -100.00% | - | Sep 30, 2023 |
| US BANCORP \DE\ | - | - | - | -44,346 | -100.00% | - | Sep 30, 2023 |
| BML CAPITAL MANAGEMENT, LLC | - | - | - | -23,749 | -100.00% | - | Sep 30, 2023 |
| SIMON QUICK ADVISORS, LLC | - | - | - | -23,428 | -100.00% | - | Sep 30, 2023 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -14,372 | -100.00% | - | Sep 30, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -8,244 | -100.00% | - | Sep 30, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -1,555 | -100.00% | - | Sep 30, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -1,504 | -100.00% | - | Sep 30, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -1,500 | -100.00% | - | Sep 30, 2023 |
| UBS GROUP AG | - | - | - | -1,100 | -100.00% | - | Sep 30, 2023 |
| - | - | - | -1,000 | -100.00% | - | Sep 30, 2023 | |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -925 | -100.00% | - | Sep 30, 2023 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -175 | -100.00% | - | Sep 30, 2023 |
Neurogene's largest sold out institutional shareholder by shares sold is BAKER BROS. ADVISORS LP, sold -3.82M shares, valued at -, as of undefined.
Neurogene Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ROYCE MICRO-CAP TRUST, INC. | 0.28% | 145,397 | - | - | Dec 31, 2023 |
| BRIDGEWAY FUNDS INC | 0.03% | 75,000 | - | - | Dec 29, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,089 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.01% | 5,484 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 49,979 | - | - | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,362 | - | - | Dec 31, 2023 |
| Humankind Benefit Corp | 0.00% | 107 | - | - | Dec 31, 2023 |
| Destra Investment Trust | 0.00% | 4,686 | - | - | Dec 31, 2023 |
| SCHWAB CAPITAL TRUST | 0.00% | 88,594 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 972,378 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 6,006 | - | - | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.00% | 4,418 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 279,557 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 3,023 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 2,623 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 24,542 | - | - | Dec 31, 2023 |
| Meeder Funds | 0.00% | 3,757 | - | - | Mar 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 15,219 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 90,100 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 266 | - | - | Apr 30, 2021 |
| OHIO NATIONAL FUND INC | 0.00% | 9,004 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,000 | - | - | Dec 31, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 13,714 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 194,475 | - | - | Dec 31, 2023 |
| Direxion Shares ETF Trust | 0.00% | 50,054 | - | - | Jan 31, 2024 |
| Victory Portfolios II | 0.00% | 16,777 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 58,533 | - | - | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 795 | - | - | Dec 29, 2023 |
| GPS Funds I | 0.00% | 1,357 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 4,286 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 250,697 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 3,000 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,301 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 1,800 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,518 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 753 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 335 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,600 | - | - | Dec 31, 2023 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 1,055 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 121,801 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 186 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 13,051 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 47,148 | - | - | Dec 31, 2023 |
| PGIM ETF TRUST | 0.00% | 2,682 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,100 | - | - | Dec 29, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 209 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,696 | - | - | Dec 31, 2023 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,619 | - | - | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 33 | - | - | Dec 31, 2023 |
| Goldman Sachs ETF Trust | 0.00% | 2,558 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 18,893 | - | - | Dec 29, 2023 |
| Pacer Funds Trust | 0.00% | 923 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 8,380 | - | - | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,505 | - | - | Dec 31, 2023 |
| ALLSPRING MASTER TRUST | 0.00% | 1,112 | - | - | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 639,054 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,619 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 3,581 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 5,547 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 29,800 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,883 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 25,930 | - | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 84 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 8,051 | 8,051 | - | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 41 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 6,893 | - | - | Dec 31, 2023 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 6,052 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 17,398 | - | - | Dec 31, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 500 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,134 | - | - | Dec 31, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 43 | - | - | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 2,887 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 250 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 4,364 | - | - | Dec 31, 2023 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 15 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 10,973 | - | - | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,695 | - | - | Dec 31, 2023 |
| BLACKROCK FUNDS | 0.00% | 3,552 | - | - | Feb 29, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 2,924 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 7,000 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 4,313 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 455 | - | - | Dec 31, 2023 |
Neurogene's largest mutual fund holder by % of total assets is "ROYCE MICRO-CAP TRUST, INC.", owning 145.40K shares, compromising 0.28% of its total assets.
Neurogene Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 23 | 36 | -2.70% |
| 31 Mar, 23 | 37 | -17.78% |
| 31 Dec, 22 | 45 | -6.25% |
| 30 Sep, 22 | 48 | -14.29% |
| 30 Jun, 22 | 56 | -29.11% |
| 31 Mar, 22 | 79 | - |
| 31 Dec, 21 | 79 | -2.47% |
| 30 Sep, 21 | 81 | -2.41% |
| 30 Jun, 21 | 83 | - |
| 31 Mar, 21 | 83 | -2.35% |
| 31 Dec, 20 | 85 | 7.59% |
| 30 Sep, 20 | 79 | 8.22% |
| 30 Jun, 20 | 73 | 19.67% |
| 31 Mar, 20 | 61 | 10.91% |
| 31 Dec, 19 | 55 | 57.14% |
| 30 Sep, 19 | 35 | - |
As of 30 Jun 23, 36 institutions are holding Neurogene's shares, representing a decrease of -2.70% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 23 | 17,401,038 | 15.56% |
| 31 Mar, 23 | 15,057,523 | -11.47% |
| 31 Dec, 22 | 17,009,152 | -9.14% |
| 30 Sep, 22 | 18,720,334 | -9.71% |
| 30 Jun, 22 | 20,732,428 | -15.65% |
| 31 Mar, 22 | 24,579,324 | -0.18% |
| 31 Dec, 21 | 24,623,326 | -4.66% |
| 30 Sep, 21 | 25,826,495 | -4.02% |
| 30 Jun, 21 | 26,908,301 | -3.07% |
| 31 Mar, 21 | 27,759,170 | 0.19% |
| 31 Dec, 20 | 27,705,909 | 0.62% |
| 30 Sep, 20 | 27,535,704 | 9.61% |
| 30 Jun, 20 | 25,121,179 | 10.42% |
| 31 Mar, 20 | 22,749,606 | 16.17% |
| 31 Dec, 19 | 19,582,953 | 3.94% |
| 30 Sep, 19 | 18,839,936 | - |
Neurogene (NLTX) has 17.40M shares outstanding as of 30 Jun 23, up 15.56% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 23 | 31.40% | 4.25% |
| 31 Mar, 23 | 27.17% | 2.86% |
| 31 Dec, 22 | 30.80% | 2.68% |
| 30 Sep, 22 | 33.88% | 2.40% |
| 30 Jun, 22 | 37.56% | 1.89% |
| 31 Mar, 22 | 44.57% | 2.23% |
| 31 Dec, 21 | 44.74% | 2.04% |
| 30 Sep, 21 | 46.88% | 1.96% |
| 30 Jun, 21 | 48.90% | 1.92% |
| 31 Mar, 21 | 50.52% | 1.93% |
| 31 Dec, 20 | 51.19% | 1.98% |
| 30 Sep, 20 | 50.88% | 1.97% |
| 30 Jun, 20 | 50.86% | 2.38% |
| 31 Mar, 20 | 46.27% | 2.92% |
| 31 Dec, 19 | 39.83% | 0.77% |
| 30 Sep, 19 | 71.95% | - |
As of 30 Jun 23, Neurogene is held by 31.40% institutional shareholders, representing a 4.25% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 13 | 30.00% |
| 31 Mar, 23 | 10 | -28.57% |
| 31 Dec, 22 | 14 | 27.27% |
| 30 Sep, 22 | 11 | -56.00% |
| 30 Jun, 22 | 25 | -35.90% |
| 31 Mar, 22 | 39 | 8.33% |
| 31 Dec, 21 | 36 | 2.86% |
| 30 Sep, 21 | 35 | -2.78% |
| 30 Jun, 21 | 36 | 24.14% |
| 31 Mar, 21 | 29 | -38.30% |
| 31 Dec, 20 | 47 | -11.32% |
| 30 Sep, 20 | 53 | 1.92% |
| 30 Jun, 20 | 52 | 44.44% |
| 31 Mar, 20 | 36 | -5.26% |
| 31 Dec, 19 | 38 | 8.57% |
| 30 Sep, 19 | 35 | - |
13 institutional shareholders have increased their position in NLTX stock as of 30 Jun 23 compared to 10 in the previous quarter (a 30.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 23 | 8 | -38.46% |
| 31 Mar, 23 | 13 | -13.33% |
| 31 Dec, 22 | 15 | -25.00% |
| 30 Sep, 22 | 20 | 5.26% |
| 30 Jun, 22 | 19 | -26.92% |
| 31 Mar, 22 | 26 | -3.70% |
| 31 Dec, 21 | 27 | - |
| 30 Sep, 21 | 27 | 12.50% |
| 30 Jun, 21 | 24 | -25.00% |
| 31 Mar, 21 | 32 | 52.38% |
| 31 Dec, 20 | 21 | 61.54% |
| 30 Sep, 20 | 13 | 8.33% |
| 30 Jun, 20 | 12 | - |
| 31 Mar, 20 | 12 | -7.69% |
| 31 Dec, 19 | 13 | - |
| 30 Sep, 19 | - | - |
8 institutional shareholders have reduced their position in NLTX stock as of 30 Jun 23 compared to 13 in the previous quarter (a -38.46% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 23 | 36 | -2.70% | 17,401,038 | 15.56% | 31.40% | 4.25% | 13 | 30.00% | 8 | -38.46% |
| 31 Mar, 23 | 37 | -17.78% | 15,057,523 | -11.47% | 27.17% | 2.86% | 10 | -28.57% | 13 | -13.33% |
| 31 Dec, 22 | 45 | -6.25% | 17,009,152 | -9.14% | 30.80% | 2.68% | 14 | 27.27% | 15 | -25.00% |
| 30 Sep, 22 | 48 | -14.29% | 18,720,334 | -9.71% | 33.88% | 2.40% | 11 | -56.00% | 20 | 5.26% |
| 30 Jun, 22 | 56 | -29.11% | 20,732,428 | -15.65% | 37.56% | 1.89% | 25 | -35.90% | 19 | -26.92% |
| 31 Mar, 22 | 79 | - | 24,579,324 | -0.18% | 44.57% | 2.23% | 39 | 8.33% | 26 | -3.70% |
| 31 Dec, 21 | 79 | -2.47% | 24,623,326 | -4.66% | 44.74% | 2.04% | 36 | 2.86% | 27 | - |
| 30 Sep, 21 | 81 | -2.41% | 25,826,495 | -4.02% | 46.88% | 1.96% | 35 | -2.78% | 27 | 12.50% |
| 30 Jun, 21 | 83 | - | 26,908,301 | -3.07% | 48.90% | 1.92% | 36 | 24.14% | 24 | -25.00% |
| 31 Mar, 21 | 83 | -2.35% | 27,759,170 | 0.19% | 50.52% | 1.93% | 29 | -38.30% | 32 | 52.38% |
| 31 Dec, 20 | 85 | 7.59% | 27,705,909 | 0.62% | 51.19% | 1.98% | 47 | -11.32% | 21 | 61.54% |
| 30 Sep, 20 | 79 | 8.22% | 27,535,704 | 9.61% | 50.88% | 1.97% | 53 | 1.92% | 13 | 8.33% |
| 30 Jun, 20 | 73 | 19.67% | 25,121,179 | 10.42% | 50.86% | 2.38% | 52 | 44.44% | 12 | - |
| 31 Mar, 20 | 61 | 10.91% | 22,749,606 | 16.17% | 46.27% | 2.92% | 36 | -5.26% | 12 | -7.69% |
| 31 Dec, 19 | 55 | 57.14% | 19,582,953 | 3.94% | 39.83% | 0.77% | 38 | 8.57% | 13 | - |
| 30 Sep, 19 | 35 | - | 18,839,936 | - | 71.95% | - | 35 | - | - | - |
Neurogene Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Neurogene's stock was made by Cvijic Christine Mikail on Dec 26 2023, selling - shares at - per share (valued at -).
Neurogene Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | 6 | - | - |
| Q4 2023 | 10 | 19 | 52.63% |
| Q3 2023 | 13 | 2 | 650.00% |
| Q2 2023 | 6 | 1 | 600.00% |
| Q1 2023 | 3 | 5 | 60.00% |
| Q3 2022 | 6 | 1 | 600.00% |
| Q2 2022 | 7 | 1 | 700.00% |
| Q1 2022 | 6 | 5 | 120.00% |
| Q4 2021 | - | - | - |
| Q3 2021 | 7 | - | - |
| Q2 2021 | 10 | 14 | 71.43% |
| Q1 2021 | 3 | 16 | 18.75% |
| Q4 2020 | 1 | - | - |
| Q3 2020 | 7 | - | - |
| Q2 2020 | 10 | 4 | 250.00% |
| Q1 2020 | 7 | 1 | 700.00% |
| Q4 2019 | 11 | 3 | 366.67% |
| Q3 2019 | 18 | - | - |
| Q3 2018 | 4 | - | - |
| Q2 2018 | 7 | 2 | 350.00% |
6 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Neurogene's insiders, as of Q1 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q3 2023 | 12 | 1 | 1200.00% |
| Q2 2023 | - | 1 | - |
| Q1 2023 | - | 2 | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | 2 | - | - |
| Q2 2021 | 2 | 14 | 14.29% |
| Q1 2021 | - | 13 | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 4 | - | - |
| Q2 2020 | 4 | 4 | 100.00% |
| Q1 2020 | 5 | - | - |
| Q4 2019 | 3 | - | - |
| Q3 2019 | 13 | - | - |
| Q3 2018 | - | - | - |
| Q2 2018 | - | 1 | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Neurogene's stocks.
NLTX Ownership FAQ
Who Owns Neurogene?
Neurogene is owned by institutional shareholders (31.40%), insiders (16.46%), and public (52.14%). The largest institutional shareholder of Neurogene is US BANCORP \DE\ (0% of total shares) and the top mutual fund owner is ROYCE MICRO-CAP TRUST, INC. (0.28% of total shares).
Who are the major institutional shareholders of Neurogene?
Neurogene's major institutional shareholders are US BANCORP \DE\, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, MORGAN STANLEY, and NATIONAL BANK OF CANADA /FI/. The top five shareholders own together 0% of the company's share outstanding.
How many Neurogene shareholders are there?
As of Jun 2023, there are 36 institutional shareholders of Neurogene.
What percentage of Neurogene is owned by US BANCORP \DE\?
US BANCORP \DE\ owns 0 shares of Neurogene, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).
What percentage of Neurogene is owned by WELLS FARGO & COMPANY/MN?
As of Sep 2023, WELLS FARGO & COMPANY/MN holds 0 shares of Neurogene (NLTX), compromising 0% of the company, valued at $0.
What percentage of Neurogene is owned by NORTHERN TRUST CORP?
NORTHERN TRUST CORP is the third largest holder of Neurogene. The company owns 0 of the company's shares outstanding (worth $0).